ABSTRACT
Aspirin has a well-established role in preventing adverse events in patients with known cardiovascular disease. However, its benefit in patients without a history of cardiovascular disease is not as clear, particularly in people with diabetes, in women, and in the elderly. Recent studies have provided insight into the risks of aspirin use, particularly bleeding, compared with its benefits in these subgroups.
Footnotes
↵* Dr. Bavry has disclosed that he has served as an independent contractor for the American College of Cardiology, and that he has received research support for the Aquarius randomized clinical trial from Novartis Pharmaceuticals and for the Translate-ACS observational study from Eli Lilly.
- Copyright © 2013 The Cleveland Clinic Foundation. All Rights Reserved.